Adenomyosis
Conditions
Interventions
Experimental group:Xueping tablet + Dienogest
Control group:Placebo + Dienogest
Sponsors
First Affiliated Hospital, Heilongjiang University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Pre-menopausal women aged 20-50 years; 2. Meet AM diagnostic criteria of Western medicine and TCM syndrome differentiation criteria; 3. No fertility requirement in recent 3 months; 4. Volunteer to participate in this study to complete clinical efficacy observation.
Exclusion criteria
Exclusion criteria: 1. Severe anemia or other severe symptoms caused by menorrhagia are not suitable to participate in this study; 2. Combined with other endocrine diseases or in the lactation period; 3. Use hormone drugs in the past 3 months; 4. Combined with serious cardiovascular and cerebrovascular diseases, liver and kidney system diseases; 5. Complicated with tuberculosis, tumor, severe anemia and other chronic wasting diseases; 6. Women with psychological or psychiatric disorders such as anxiety or depression symptoms; 7. Known to be allergic to the drugs in this experiment; 8. Currently participating in other clinical investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale (VAS) for dysmenorrhea; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;Transvaginal uterine color ultrasound image;CA125;Blood hemorheology;Mean vessel density;Related blood indicators; | — |
Countries
China
Contacts
Public ContactSun Miao
Outcome results
None listed